Mirugen, Pty.
Latest round
- Seed
Last raised
- Aug 2025
Total raised
- $2.9M
Investors
- 4
About Mirugen, Pty.
Founded in 2022 and headquartered in Melbourne, Australia, Mirugen, Pty. Ltd. specializes in cell reprogramming therapies. In August 2025, Mirugen, Pty. Ltd. Mirugen operates at the forefront of cell reprogramming to address significant health challenges associated with blindness. The company's primary focus is on leveraging its discovery platform, which integrates sequencing data, bioinformatics, and high-throughput screening, to identify key transcription factors that facilitate the conversion of one cell type into another. Their pioneering approach targets Muller Glial cells in the eye, aiming to regenerate lost photoreceptors, which are essential for vision.5 million individuals globally, with potential applications extending to other prevalent eye diseases such as Age-related Macular Degeneration and Stargardt’s disease.Mirugen's revenue model is structured around partnerships and collaborations with clinical research organizations, academic institutions, and potentially commercial pharmaceutical companies engaged in gene therapy and regenerative medicine. Transactions typically occur through direct collaboration agreements, which may involve milestone-based payments tied to research and development progress, as well as potential licensing of proprietary technologies for commercial use. While specific pricing plans for their services are not disclosed, it can be anticipated that such transactions will align with industry standards, involving negotiated fees based on the scope and scale of the projects.In August 2025, Mirugen, Pty. Ltd. Future growth initiatives include the development of new products aimed at enhancing therapeutic solutions for retinal diseases, with specific release dates to be determined. Additionally, Mirugen plans to expand its market presence into new geographic regions, including Asia and Europe, by the end of 2026.
Who invested in Mirugen, Pty.
4 investors across 1 round
See all investors in Mirugen, Pty.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 13, 2025
Amount
$2.9M
Investors
Questions about Mirugen, Pty.
Who invested in Mirugen, Pty.?
Mirugen, Pty. has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mirugen, Pty. raised?
Mirugen, Pty. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mirugen, Pty. last raise money?
Mirugen, Pty.'s most recent round on record is a Seed, in Aug 2025.
What does Mirugen, Pty. do?
Founded in 2022 and headquartered in Melbourne, Australia, Mirugen, Pty.
Where is Mirugen, Pty. headquartered?
Mirugen, Pty. is headquartered in Melbourne, Australia.
Which VCs invest in companies like Mirugen, Pty.?
Among active investors with capital left to deploy, Blackbird, AirTree Ventures, Square Peg and Immutable Ventures back biotechnology companies at Mirugen, Pty.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Mirugen, Pty.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.